Skip to main content
. 2019 Jan-Feb;51(1):11–16. doi: 10.4103/ijp.IJP_536_18

Table 2.

ARRIVE checklist for methods (item number 7 and 8)

Item Number Recommendation Yes (%) No (%) 95% CI
Methods
Experimental procedures 7 For each experiment and each experimental group, including controls, provide precise details of all procedures carried out. For example
(a) How (e.g., drug formulation and dose, site and route of administration, anesthesia, and analgesia used [including monitoring], surgical procedure, method of euthanasia). Provide details of any specialist equipment used, including supplier (s) 161 (100) 0 1 (0.97-1)
(b) When (e.g., time of day) 12 (7.45) 149 (92.55) 0.07 (0.04-0.12)
(c) Where (e.g., home cage, laboratory, and water maze) 23 (14.29) 138 (85.71) 0.14 (0.09-0.20)
(d) Why (e.g., rationale for choice of specific anesthetic, route of administration, and drug dose used) 0 161 -
Experimental animals 8 (a) Provide details of the animals used, including species, strain, sex, developmental stage (e.g., mean or median age plus age range), and weight (e.g., mean or median weight plus weight range) 153 (95.03) 8 (4.97) 0.95 (0.90-0.97)
(b) Provide further relevant information such as the source of animals, international strain nomenclature, genetic modification status (e.g., knock-out or transgenic), genotype, health/immune status, drug or test naıve, previous procedures. 158 (98.14) 3 (1.86) 0.98 (0.94-0.99)

CI=Confidence interval